^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ATG-034

    i
    Other names: ATG-034
    Associations
    News
    Trials
    Company:
    Antengene
    Drug class:
    ILT-3 antagonist
    Associations
    News
    Trials